Advertisement FDA gives marketing approval for Teva generic Alzheimer's drug - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

FDA gives marketing approval for Teva generic Alzheimer’s drug

The US Food and Drug Administration (FDA) has given marketing approval to Teva Pharmaceutical Industries' abbreviated new drug application (ANDA) for the generic version of Eisai's Aricept (Donepezil Hydrochloride) Tablets, 5mg and 10mg.

Aricept is the US Food and Drug Administration (FDA) approved prescription only medication for the treatment of all stages of Alzheimer’s disease – mild, moderate and severe dementia of the Alzheimer’s type.

Aricept improves the function of nerve cells in the brain and works by preventing the breakdown of a chemical called acetylcholine.